BELLICUM PHARMACEUTICALS, INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2014 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bellicum Pharmaceuticals, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2014 to Q3 2023.
  • Bellicum Pharmaceuticals, Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$763K, a 89.4% increase year-over-year.
  • Bellicum Pharmaceuticals, Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$22.4M, a 37.8% decline year-over-year.
  • Bellicum Pharmaceuticals, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$25M, a 157% decline from 2021.
  • Bellicum Pharmaceuticals, Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$9.71M, a 25.7% decline from 2020.
  • Bellicum Pharmaceuticals, Inc annual Net Income (Loss) Attributable to Parent for 2020 was -$7.72M, a 93.1% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$22.4M -$763K +$6.45M +89.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$28.8M -$7.35M -$3.35M -83.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$25.5M -$8.07M -$504K -6.67% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$25M -$6.2M -$8.73M -345% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 -$16.2M -$7.21M -$8.45M -685% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$7.8M -$4M -$1.8M -81.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$6M -$7.56M +$3.71M +32.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$9.71M $2.53M -$16.3M -86.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $6.55M $1.23M +$2.12M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $4.43M -$2.2M +$41M +94.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$36.6M -$11.3M -$28.8M -164% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$7.72M $18.8M +$47.8M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$55.5M -$887K +$31.1M +97.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$86.6M -$43.2M -$16.3M -60.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$70.4M $17.6M +$42.1M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$112M -$29M -$1.76M -6.47% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-12
Q3 2019 -$111M -$32M -$8.23M -34.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$102M -$26.9M -$2.76M -11.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$99.7M -$24.5M -$1.69M -7.39% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$98M -$27.2M -$5.3M -24.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$92.7M -$23.8M -$370K -1.58% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$92.4M -$24.2M +$282K +1.15% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$92.6M -$22.8M -$867K -3.95% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$91.8M -$21.9M -$1.98M -9.93% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$89.8M -$23.4M -$5.71M -32.2% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-12
Q2 2017 -$84.1M -$24.5M -$7.95M -48.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-12
Q1 2017 -$76.1M -$22M -$6.9M -45.8% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-12
Q4 2016 -$69.2M -$19.9M -$3.09M -18.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-13
Q3 2016 -$66.2M -$17.7M -$4.31M -32.2% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-13
Q2 2016 -$61.8M -$16.5M -$5.98M -56.7% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-13
Q1 2016 -$55.9M -$15.1M -$7.32M -94.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-13
Q4 2015 -$48.5M -$16.8M +$57.5M +77.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-13
Q3 2015 -$106M -$13.4M -$9.31M -227% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-13
Q2 2015 -$96.7M -$10.5M -$7.25M -221% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-13
Q1 2015 -$89.4M -$7.76M -$5.47M -239% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-13
Q4 2014 -$84M -$74.3M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-14
Q3 2014 -$4.1M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-14
Q2 2014 -$3.28M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-14
Q1 2014 -$2.29M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.